This large retrospective study investigating the effect of ovulation-stimulating drugs on the
subsequent risk of ovarian cancer included infertility patients from 5 large reproductive …

OBJECTIVE: To assess the long-term effects of ovulation-stimulating drugs on the risk of
ovarian cancer. METHODS: A retrospective cohort study of 12,193 eligible study subjects …

Objectives: To assess the determinants of change in clinical practice patterns of physicians
with respect to the use of ovulation inductio drugs and the potential for an increased risk of …

Infertility itself increases the incidence of ovarian carcinoma, while the potential additional
risk associated with the use of fertility drugs is still debated. In 1992, the cumulative analysis …

Background Case reports and the results of a recent case-control study have raised
questions about the potential neoplastic effects of medications used as treatment for …

Objective To review critically the published data regarding the proposed association of
ovulation induction, infertility, and an increased risk of ovarian cancer. Design A medline …

The risk of developing gynaecological cancer following ovulation induction therapy in
infertile patients is not easy to determine due to many confounding factors. These include …

Background Questions have been raised regarding the potential association of ovulation-
inducing drugs and ovarian cancer. Worldwide there have been 13 cases of ovarian …

Many couples faced with infertility are treated with ovulation inducing medicines. Recently,
concerns have been raised about the possible risk of ovarian malignancy after such ovarian …

Over the past decades, the use of ovulation inducing drugs has been increasing. A possible
causal link between fertility treatments (especially clomiphene citrate and gonadotrophins) …